Status:
ACTIVE_NOT_RECRUITING
Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Region Stockholm
Conditions:
High-grade Cervical Intraepithelial Neoplasia
Invasive Cervical Cancer
Eligibility:
FEMALE
30-64 years
Phase:
NA
Brief Summary
The purpose is to evaluate whether implementation of primary human papillomavirus (HPV) screening in the screening programme for cervical cancer improves the programme in terms of better cancer protec...
Detailed Description
Primary HPV screening is a method with higher sensitivity than cytology for detection of high-grade cervical intraepithelial neoplasia, which is the precursor of cervical cancer. In particular, HPV te...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Women between the age 30 and 64 years resident in the Stockholm-Gotland region. No exclusion criteria.
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2031
Estimated Enrollment :
270000 Patients enrolled
Trial Details
Trial ID
NCT01511328
Start Date
January 1 2012
End Date
December 1 2031
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden, 141 86